BJ
Bruce N. Jacobs
Chief Financial Officer

Bruce N. Jacobs insider trades: Kymera Therapeutics (KYMR) stock sales

Chief Financial Officer, Kymera Therapeutics Last trade Jun 30, 2026 28 Form 4 filings
$10.0M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Bruce reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 30, 2026KYMR↓ Sell$8.9M
Mar 4, 2026KYMR↓ Sell$1.1M
Sep 17, 2025KYMR↓ Sell$4.0M
Mar 3, 2025KYMR↓ Sell$214K
Mar 4, 2024KYMR↓ Sell$165K
Mar 2, 2023KYMR↓ Sell$42K
Jan 12, 2022KYMR↓ Sell$778K
Dec 3, 2021KYMR↓ Sell$536K
Sep 3, 2021KYMR↓ Sell$601K
Jun 3, 2021KYMR↓ Sell$469K
Mar 15, 2021KYMR↓ Sell$602K
Mar 8, 2021KYMR↓ Sell$506K
Mar 3, 2021KYMR↓ Sell$896K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other KYMR insiders

Open-market trades in the last 12 months

About Bruce N. Jacobs's insider trades

Bruce N. Jacobs is Chief Financial Officer at Kymera Therapeutics (KYMR). Since Mar 3, 2021, Bruce has reported no open-market purchases and 13 sales worth $18.7M on SEC Form 4. In the last 12 months: 2 sales ($10.0M).

Their filings also include option exercises (21 filings), grants and awards (9 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KYMR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.